Peter Vis
Impact in
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
-
- Pharmaceutical studies and practices
- Neonatal and fetal brain pathology
Papers in
-
- Pharmaceutical studies and practices 6
- Neonatal and fetal brain pathology 3
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Jos Delbeke (5 shared papers)Sarah C. McLeay (2 shared papers)Bruce Green (2 shared papers)Rolf P. G. van Heeswijk (1 shared paper)Thomas N. Kakuda (4 shared papers)Meindert Danhof (2 shared papers)Anita Shah (2 shared papers)Dirk Garmann (2 shared papers)
- Journals
- Pediatric Research (2 papers)Journal of the International AIDS Society (2 papers)Expert Review of Clinical Pharmacology (1 paper)Environment and Development Economics (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
Peter Vis
31 papers receiving 439 citations
Peers
Comparison fields: 5 of 77
- Infectious Diseases 213
- Pediatrics, Perinatology and Child Health 48
- Hematology 46
- Pharmacology 30
- Energy Engineering and Power Technology 6
Countries citing papers authored by Peter Vis
This map shows the geographic impact of Peter Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vis more than expected).
Fields of papers citing papers by Peter Vis
This network shows the impact of papers produced by Peter Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vis. The network helps show where Peter Vis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Vis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2019 | 61 | |
| 3 | 2009 | 40 | |
| 4 | 2010 | 40 | |
| 5 | 2017 | 35 | |
| 6 | 2012 | 30 | |
| 7 | 1994 | 29 | |
| 8 | 2010 | 21 | |
| 9 | 2014 | 15 | |
| 10 | 2019 | 15 | |
| 11 | 2016 | 14 | |
| 12 | 2019 | 14 | |
| 13 | 2010 | 13 | |
| 14 | 2015 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2001 | 8 | |
| 17 | 2020 | 8 | |
| 18 | EU climate policy explained | 2015 | 7 |
| 19 | 2010 | 4 | |
| 20 | 2016 | 4 |
About Peter Vis
Peter Vis is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases, Economics and Econometrics, Pharmacology and Hematology, having authored 32 papers that have together received 468 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Climate Change Policy and Economics (7 papers), Pharmaceutical studies and practices (6 papers), Neonatal and fetal brain pathology (3 papers), Hemophilia Treatment and Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Infectious Diseases (213 citations), Pediatrics, Perinatology and Child Health (48 citations), Hematology (46 citations), Pharmacology (30 citations) and Energy Engineering and Power Technology (6 citations). Peter Vis has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Jos Delbeke, Sarah C. McLeay, Bruce Green, Rolf P. G. van Heeswijk, Thomas N. Kakuda, Meindert Danhof, Anita Shah, Dirk Garmann, Vanitha J. Sekar and Rob A. Voskuyl. Their work appears in journals such as Pediatric Research, Journal of the International AIDS Society, Expert Review of Clinical Pharmacology, Environment and Development Economics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.